ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

EBS Emergent Biosolutions Inc

3.88
0.58 (17.58%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Emergent Biosolutions Inc EBS NYSE 普通株式
  前日比 前日比 % 現在値 時刻
0.58 17.58% 3.88 09:00:00
始値 安値 高値 終値 前日終値
3.45 3.36 4.02 3.89 3.30
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0205:57GLOBEEmergent BioSolutions Reports First Quarter 2024 Financial..
2024/5/0205:10GLOBEEmergent BioSolutions Announces Strategic Operational..
2024/5/0200:03GLOBEEmergent BioSolutions Releases New Survey Findings..
2024/5/0106:26GLOBEEmergent BioSolutions Announces Amendment to its Existing..
2024/4/2221:05GLOBEEmergent BioSolutions to Release First Quarter 2024..
2024/4/0121:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
2024/3/2821:15GLOBEEmergent BioSolutions Continues to Broaden Access, Awareness..
2024/3/2521:05GLOBEEmergent BioSolutions Receives NAI Status for Baltimore..
2024/3/0906:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0810:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:31GLOBEEmergent BioSolutions Reports Fourth Quarter 2023 Financial..
2024/3/0706:15EDGAR2Form 8-K - Current report
2024/3/0620:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
2024/3/0508:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0508:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0508:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2921:00GLOBEEmergent BioSolutions to Release Fourth Quarter & Full Year..
2024/2/2810:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2810:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2121:25EDGAR2Form 8-K - Current report
2024/2/2121:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
2024/1/1121:41EDGAR2Form 8-K - Current report
2024/1/0922:40EDGAR2Form 8-K - Current report
2024/1/0921:30GLOBEEmergent BioSolutions to Present at the 42nd Annual J.P...
2023/12/2720:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
2023/12/1207:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/1121:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/2821:15EDGAR2Form 8-K - Current report
2023/11/2820:59GLOBEEmergent BioSolutions Receives $75 Million Contract Option..
2023/11/2421:30GLOBEEmergent BioSolutions Receives NYSE Notice Regarding Delayed..
2023/11/2421:17EDGAR2Form 8-K - Current report
2023/11/1706:11EDGAR2Form 8-K - Current report
2023/11/1509:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1509:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1509:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1006:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
2023/11/0907:38GLOBEEmergent BioSolutions Reports Third Quarter 2023 Financial..
2023/11/0906:21EDGAR2Form 8-K - Current report
2023/10/3105:45GLOBEUPDATE: Emergent BioSolutions to Release Third Quarter 2023..
2023/10/1919:30GLOBEEmergent BioSolutions to Release Third Quarter 2023..
2023/10/1620:00PRNUSEmergent BioSolutions Partners with Emmitt Smith to Launch..
2023/10/0608:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0608:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0608:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0608:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0520:42EDGAR2Form 8-K - Current report
2023/10/0220:49EDGAR2Form 8-K - Current report
2023/10/0220:00GLOBEEmergent BioSolutions Names Two Pharmaceutical Industry..
2023/8/3019:30EDGAR2Form 8-K - Current report
2023/8/3018:59GLOBEEmergent BioSolutions’ NARCAN® Nasal Spray Launches Over the..

最近閲覧した銘柄

Delayed Upgrade Clock